Michele Teng

Associate Professor Michele Teng is head of the Cancer Immunoregulation and Immunotherapy Laboratory at QIMR Berghofer (Queensland Institute of Medical Research). Over her career, she has published 106 peer-reviewed primary papers and reviews in high-impact journals such as Cancer Discovery, Cancer Research, Nature Medicine, Nature Reviews Clinical Oncology and Lancet Oncology. Her group investigates how tumour-induced immune suppression impedes the effective treatment of established cancer. Achieving a better understanding of immunosuppressive pathways will enable the rational improvement of treatments for patients with established cancer.

You can find more articles by this contributor with the search function by entering their name.